• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

预防性阿司匹林与老年人群

Prophylactic aspirin and the elderly population.

作者信息

Dalen J E, Goldberg R J

机构信息

College of Medicine, University of Arizona, Tucson.

出版信息

Clin Geriatr Med. 1992 Feb;8(1):119-26.

PMID:1576570
Abstract

A wide array of clinical trials over the past two decades has established that aspirin is indicated to prevent myocardial infarction in patients with clinically evident coronary artery disease, and to prevent stroke in patients with a history of stroke or TIAs. The most likely mechanism by which aspirin decreases the incidence of myocardial infarction is by preventing coronary thrombosis in patients with obstructive coronary artery disease. This protective effect of aspirin should occur in patients with both clinically silent and clinically evident coronary artery disease. For this reason, it has been recommended that patients with risk factors for coronary artery disease also should be treated with prophylactic aspirin. Advanced age is one of the strongest risk factors for coronary artery disease, and the mortality of myocardial infarction rises steeply with increased age. A prospective randomized study of US male physicians without a history of myocardial infarction demonstrated a 44% reduction in myocardial infarction in those treated with 325 mg aspirin every other day. The treatment effect occurred only in those aged 50 or older. A prospective study of US nurses aged 34 to 65, without a history of diagnosed coronary artery disease, demonstrated a 32% decrease in those who took one to six aspirin per week. Again, the treatment effect was seen only in those aged 50 or older. Given these findings, the authors believe that prophylactic aspirin is indicated in men and women aged 50 or older who do not have contraindications to its use. The authors recommend a dose of 325 mg of aspirin every other day, a dose with minimal side effects.

摘要

在过去二十年中,大量临床试验已证实,阿司匹林可用于预防有明显临床症状的冠状动脉疾病患者发生心肌梗死,以及预防有中风或短暂性脑缺血发作病史的患者发生中风。阿司匹林降低心肌梗死发病率最可能的机制是预防阻塞性冠状动脉疾病患者的冠状动脉血栓形成。阿司匹林的这种保护作用在临床无症状和有明显临床症状的冠状动脉疾病患者中均应出现。因此,有人建议有冠状动脉疾病危险因素的患者也应接受预防性阿司匹林治疗。高龄是冠状动脉疾病最强的危险因素之一,心肌梗死的死亡率随年龄增长而急剧上升。一项针对无心肌梗死病史的美国男性医生的前瞻性随机研究表明,每隔一天服用325毫克阿司匹林的患者心肌梗死发生率降低了44%。治疗效果仅出现在50岁及以上的人群中。一项针对年龄在34至65岁、无确诊冠状动脉疾病病史的美国护士的前瞻性研究表明,每周服用一至六片阿司匹林的护士心肌梗死发生率降低了32%。同样,治疗效果仅在50岁及以上的人群中出现。基于这些发现,作者认为,对于50岁及以上且无使用阿司匹林禁忌证的男性和女性,应使用预防性阿司匹林。作者建议每隔一天服用325毫克阿司匹林,该剂量副作用最小。

相似文献

1
Prophylactic aspirin and the elderly population.预防性阿司匹林与老年人群
Clin Geriatr Med. 1992 Feb;8(1):119-26.
2
Aspirin to prevent heart attack and stroke: what's the right dose?阿司匹林预防心脏病发作和中风:合适的剂量是多少?
Am J Med. 2006 Mar;119(3):198-202. doi: 10.1016/j.amjmed.2005.11.013.
3
Update on aspirin in the treatment and prevention of cardiovascular disease.阿司匹林在心血管疾病治疗与预防中的最新进展。
Am J Manag Care. 2002 Dec;8(22 Suppl):S691-700.
4
Prior peripheral arterial disease and cerebrovascular disease are independent predictors of adverse outcome in patients with acute coronary syndromes: are we doing enough? Results from the Orbofiban in Patients with Unstable Coronary Syndromes-Thrombolysis In Myocardial Infarction (OPUS-TIMI) 16 study.既往外周动脉疾病和脑血管疾病是急性冠脉综合征患者不良预后的独立预测因素:我们做得够吗?来自不稳定冠脉综合征患者使用orbofiban-心肌梗死溶栓治疗(OPUS-TIMI)16研究的结果。
Am Heart J. 2003 Apr;145(4):622-7. doi: 10.1067/mhj.2003.6.
5
Aspirin for prevention of myocardial infarction. A double-edged sword.阿司匹林用于预防心肌梗死。一把双刃剑。
Ann Med Interne (Paris). 1997;148(6):430-3.
6
[Characteristics of patients with coronary disease and aspirin prescription in Haute-Garonne].[上加龙省冠心病患者及阿司匹林处方的特点]
Ann Cardiol Angeiol (Paris). 1994 Dec;43(10):588-93.
7
Major clinical vascular events and aspirin-resistance status as determined by the PFA-100 method among patients with stable coronary artery disease: a prospective study.通过PFA-100法测定的稳定型冠心病患者的主要临床血管事件及阿司匹林抵抗状态:一项前瞻性研究
Blood Coagul Fibrinolysis. 2008 Apr;19(3):235-9. doi: 10.1097/MBC.0b013e3282f9ade8.
8
Aspirin use in the prevention of cardiovascular events.阿司匹林在心血管事件预防中的应用。
J Okla State Med Assoc. 2007 Oct;100(10):383-7.
9
Effect of xuezhikang on cardiovascular events and mortality in elderly patients with a history of myocardial infarction: a subgroup analysis of elderly subjects from the China Coronary Secondary Prevention Study.血脂康对有心肌梗死病史老年患者心血管事件及死亡率的影响:中国冠心病二级预防研究老年受试者的亚组分析
J Am Geriatr Soc. 2007 Jul;55(7):1015-22. doi: 10.1111/j.1532-5415.2007.01230.x.
10
The use of antithrombotic drugs in artery disease.抗血栓药物在动脉疾病中的应用。
Clin Haematol. 1986 May;15(2):509-59.

引用本文的文献

1
Insulin-like growth factor-2 is a promising candidate for the treatment and prevention of Alzheimer's disease.胰岛素样生长因子-2 是治疗和预防阿尔茨海默病的有前途的候选药物。
CNS Neurosci Ther. 2023 Jun;29(6):1449-1469. doi: 10.1111/cns.14160. Epub 2023 Mar 27.